Longeveron(LGVN)
MIAMI, FL
BiotechnologyFocus: Stem Cells to combat aging
We are a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. Through patient-focused, regenerative medicine, our research and therapies are aimed at improving healthspan.
Cell Therapy
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Longeveron Mesenchymal Stem Cells
Alzheimer's DiseaseClinical Trials (1)
NCT02600130Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease
Phase 1Longeveron Mesenchymal Stem Cells
ARDS, HumanClinical Trials (1)
NCT04629105Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)
Phase 1Allo-hMSCs
Hypoplastic Left Heart SyndromeClinical Trials (1)
NCT02398604Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome
Phase 1Longeveron Mesenchymal Stem Cells
HLHSClinical Trials (1)
NCT03525418Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)
Phase 1/2Allogeneic Human Mesenchymal Stem Cells
FrailtyClinical Trials (1)
NCT02065245AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery
Phase 1/2Longeveron Mesenchymal Stem Cells
Aging FrailtyClinical Trials (1)
NCT02982915Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty
Phase 1/2Lomecel-B medicinal signaling cells
Hypoplastic Left Heart SyndromeClinical Trials (1)
NCT04925024Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.
Phase 2Allogeneic MSC
Mild Alzheimer's DiseaseClinical Trials (1)
NCT05233774Lomecel-B Effects on Alzheimer's Disease
Phase 2Peripheral Intravenous
Metabolic DiseaseClinical Trials (1)
NCT02587572Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial
Phase 2Longeveron Mesenchymal Stem Cells
Aging FrailtyClinical Trials (1)
NCT03169231Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 10 clinical trials
Top TAs: Neurology, Infectious Diseases
Publications: 12 in PubMed
SEC Filings: 2 available
Financials (FY2024)
Revenue
$709K42%
R&D Spend
$9M(1279%)3%
Net Income
-$21MCash
$5MHiring Trend
Stable
0
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles